Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Androgenetic alopecia causes hair loss by shrinking hair follicles due to androgens, with the connection between the muscle and hair follicle determining if the loss is reversible.

Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Stress might contribute to hair loss in alopecia areata.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Disrupted stem cell signals in hairpoor mice cause hair loss.

Two mouse mutations cause similar hair loss despite different skin changes.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Hair follicle stem cells in hairpoor mice are disrupted, causing hair loss.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.